マイクロドーズの^<14>C標識化合物の静脈内投与と Accelerator Mass Spectrometry 分析を用いたイヌ経口バイオアベイラビリティの算出

スポンサーリンク

概要

論文の詳細を見る
2009-04-25

著者

KURIHARA Atsushi
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
IKEDA Toshihiko
Yokohama College of Pharmacy
MIYAJI Yoshihiro
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi-Sankyo Co., LTD.
ISHIZUKA Tomoko
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi-Sankyo Co., LTD.
KAWAI Kenji
Examination Promote Department Pharmacokinetics and Bioanalysis Center Contract Research Company, Si
HAMABE Yoshimi
Motomiya Pharmacokinetics Analysis Center, Institute of Accelerator Analysis Ltd.
MIYAOKA Teiji
Institute of Accelerator Analysis Ltd.
OH-HARA Toshinari
ADME & TOX, Research Institute, SEKISUI MEDICAL Co., Ltd.
Miyaoka Teiji
Institute Of Accelerator Analysis (iaa) Ltd.
Hamabe Yoshimi
Motomiya Pharmacokinetics Analysis Center Institute Of Accelerator Analysis Ltd.
Kurihara Atsushi
Drug Metabolism And Pharmacokinetics Research Laboratories Daiichi-sankyo Co. Ltd.
Ishizuka Tomoko
Drug Metabolism And Pharmacokinetics Research Laboratories Daiichi-sankyo Co. Ltd.
Miyaji Yoshihiro
Drug Metabolism And Pharmacokinetics Research Laboratories Daiichi-sankyo Co. Ltd.
Oh-hara Toshinari
Adme & Tox Research Institute Sekisui Medical Co. Ltd.
Kawai Kenji
Examination Promote Department Pharmacokinetics And Bioanalysis Center Contract Research Company Sin
Ikeda Toshihiko
Yokohama Coll. Of Pharmacy

関連論文

スポンサーリンク